The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
Identifieur interne : 000E35 ( Ncbi/Merge ); précédent : 000E34; suivant : 000E36The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
Auteurs : John Mair-Jenkins ; Maria Saavedra-Campos ; J Kenneth Baillie [Royaume-Uni] ; Paul Cleary ; Fu-Meng Khaw ; Wei Shen Lim ; Sophia Makki ; Kevin D. Rooney [Royaume-Uni] ; Jonathan S. Nguyen-Van-Tam ; Charles R. Beck [Royaume-Uni]Source :
- The Journal of infectious diseases [ 1537-6613 ] ; 2015.
Descripteurs français
- KwdFr :
- Grippe humaine (immunologie), Grippe humaine (traitement médicamenteux), Humains, Immunoglobulines (administration et posologie), Immunoglobulines (immunologie), Infections de l'appareil respiratoire (immunologie), Plasma sanguin (immunologie), Risque, Syndrome respiratoire aigu sévère (immunologie), Syndrome respiratoire aigu sévère (traitement médicamenteux), Virus du SRAS (immunologie), Études prospectives.
- MESH :
- administration et posologie : Immunoglobulines.
- immunologie : Grippe humaine, Immunoglobulines, Infections de l'appareil respiratoire, Plasma sanguin, Syndrome respiratoire aigu sévère, Virus du SRAS.
- traitement médicamenteux : Grippe humaine, Syndrome respiratoire aigu sévère.
- Humains, Risque, Études prospectives.
English descriptors
- KwdEn :
- Humans, Immunoglobulins (administration & dosage), Immunoglobulins (immunology), Influenza, Human (drug therapy), Influenza, Human (immunology), Plasma (immunology), Prospective Studies, Respiratory Tract Infections (immunology), Risk, SARS Virus (immunology), Severe Acute Respiratory Syndrome (drug therapy), Severe Acute Respiratory Syndrome (immunology).
- MESH :
- chemical , administration & dosage : Immunoglobulins.
- chemical , immunology : Immunoglobulins.
- drug therapy : Influenza, Human, Severe Acute Respiratory Syndrome.
- immunology : Influenza, Human, Plasma, Respiratory Tract Infections, SARS Virus, Severe Acute Respiratory Syndrome.
- Humans, Prospective Studies, Risk.
Abstract
Administration of convalescent plasma, serum, or hyperimmune immunoglobulin may be of clinical benefit for treatment of severe acute respiratory infections (SARIs) of viral etiology. We conducted a systematic review and exploratory meta-analysis to assess the overall evidence.
DOI: 10.1093/infdis/jiu396
PubMed: 25030060
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001913
- to stream PubMed, to step Curation: 001913
- to stream PubMed, to step Checkpoint: 001315
Links to Exploration step
pubmed:25030060Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.</title><author><name sortKey="Mair Jenkins, John" sort="Mair Jenkins, John" uniqKey="Mair Jenkins J" first="John" last="Mair-Jenkins">John Mair-Jenkins</name><affiliation><nlm:affiliation>East Midlands Centre, Public Health England.</nlm:affiliation><wicri:noCountry code="subField">Public Health England</wicri:noCountry></affiliation></author><author><name sortKey="Saavedra Campos, Maria" sort="Saavedra Campos, Maria" uniqKey="Saavedra Campos M" first="Maria" last="Saavedra-Campos">Maria Saavedra-Campos</name><affiliation><nlm:affiliation>Field Epidemiology Training Programme, Public Health England, London Field Epidemiology Service, Public Health England, Liverpool.</nlm:affiliation><wicri:noCountry code="subField">Liverpool</wicri:noCountry></affiliation></author><author><name sortKey="Baillie, J Kenneth" sort="Baillie, J Kenneth" uniqKey="Baillie J" first="J Kenneth" last="Baillie">J Kenneth Baillie</name><affiliation wicri:level="4"><nlm:affiliation>Roslin Institute, University of Edinburgh, Midlothian.</nlm:affiliation><orgName type="university">Université d'Édimbourg</orgName><country>Royaume-Uni</country><placeName><settlement type="city">Édimbourg</settlement><region type="country">Écosse</region></placeName></affiliation></author><author><name sortKey="Cleary, Paul" sort="Cleary, Paul" uniqKey="Cleary P" first="Paul" last="Cleary">Paul Cleary</name><affiliation><nlm:affiliation>Field Epidemiology Service, Public Health England, Liverpool.</nlm:affiliation><wicri:noCountry code="subField">Liverpool</wicri:noCountry></affiliation></author><author><name sortKey="Khaw, Fu Meng" sort="Khaw, Fu Meng" uniqKey="Khaw F" first="Fu-Meng" last="Khaw">Fu-Meng Khaw</name><affiliation><nlm:affiliation>East Midlands Centre, Public Health England.</nlm:affiliation><wicri:noCountry code="subField">Public Health England</wicri:noCountry></affiliation></author><author><name sortKey="Lim, Wei Shen" sort="Lim, Wei Shen" uniqKey="Lim W" first="Wei Shen" last="Lim">Wei Shen Lim</name><affiliation><nlm:affiliation>Respiratory Medicine, Nottingham University Hospitals NHS Trust.</nlm:affiliation><wicri:noCountry code="subField">Nottingham University Hospitals NHS Trust</wicri:noCountry></affiliation></author><author><name sortKey="Makki, Sophia" sort="Makki, Sophia" uniqKey="Makki S" first="Sophia" last="Makki">Sophia Makki</name><affiliation><nlm:affiliation>East Midlands Centre, Public Health England.</nlm:affiliation><wicri:noCountry code="subField">Public Health England</wicri:noCountry></affiliation></author><author><name sortKey="Rooney, Kevin D" sort="Rooney, Kevin D" uniqKey="Rooney K" first="Kevin D" last="Rooney">Kevin D. Rooney</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Care and Practice Improvement, University of the West of Scotland, Hamilton, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Care and Practice Improvement, University of the West of Scotland, Hamilton</wicri:regionArea><wicri:noRegion>Hamilton</wicri:noRegion></affiliation></author><author><name sortKey="Nguyen Van Tam, Jonathan S" sort="Nguyen Van Tam, Jonathan S" uniqKey="Nguyen Van Tam J" first="Jonathan S" last="Nguyen-Van-Tam">Jonathan S. Nguyen-Van-Tam</name></author><author><name sortKey="Beck, Charles R" sort="Beck, Charles R" uniqKey="Beck C" first="Charles R" last="Beck">Charles R. Beck</name><affiliation wicri:level="4"><nlm:affiliation>Division of Epidemiology and Public Health, University of Nottingham, Nottingham.</nlm:affiliation><orgName type="university">Université de Nottingham</orgName><country>Royaume-Uni</country><placeName><settlement type="city">Nottingham</settlement><region type="nation">Angleterre</region><region type="région" nuts="1">Nottinghamshire</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25030060</idno><idno type="pmid">25030060</idno><idno type="doi">10.1093/infdis/jiu396</idno><idno type="wicri:Area/PubMed/Corpus">001913</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001913</idno><idno type="wicri:Area/PubMed/Curation">001913</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001913</idno><idno type="wicri:Area/PubMed/Checkpoint">001315</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001315</idno><idno type="wicri:Area/Ncbi/Merge">000E35</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.</title><author><name sortKey="Mair Jenkins, John" sort="Mair Jenkins, John" uniqKey="Mair Jenkins J" first="John" last="Mair-Jenkins">John Mair-Jenkins</name><affiliation><nlm:affiliation>East Midlands Centre, Public Health England.</nlm:affiliation><wicri:noCountry code="subField">Public Health England</wicri:noCountry></affiliation></author><author><name sortKey="Saavedra Campos, Maria" sort="Saavedra Campos, Maria" uniqKey="Saavedra Campos M" first="Maria" last="Saavedra-Campos">Maria Saavedra-Campos</name><affiliation><nlm:affiliation>Field Epidemiology Training Programme, Public Health England, London Field Epidemiology Service, Public Health England, Liverpool.</nlm:affiliation><wicri:noCountry code="subField">Liverpool</wicri:noCountry></affiliation></author><author><name sortKey="Baillie, J Kenneth" sort="Baillie, J Kenneth" uniqKey="Baillie J" first="J Kenneth" last="Baillie">J Kenneth Baillie</name><affiliation wicri:level="4"><nlm:affiliation>Roslin Institute, University of Edinburgh, Midlothian.</nlm:affiliation><orgName type="university">Université d'Édimbourg</orgName><country>Royaume-Uni</country><placeName><settlement type="city">Édimbourg</settlement><region type="country">Écosse</region></placeName></affiliation></author><author><name sortKey="Cleary, Paul" sort="Cleary, Paul" uniqKey="Cleary P" first="Paul" last="Cleary">Paul Cleary</name><affiliation><nlm:affiliation>Field Epidemiology Service, Public Health England, Liverpool.</nlm:affiliation><wicri:noCountry code="subField">Liverpool</wicri:noCountry></affiliation></author><author><name sortKey="Khaw, Fu Meng" sort="Khaw, Fu Meng" uniqKey="Khaw F" first="Fu-Meng" last="Khaw">Fu-Meng Khaw</name><affiliation><nlm:affiliation>East Midlands Centre, Public Health England.</nlm:affiliation><wicri:noCountry code="subField">Public Health England</wicri:noCountry></affiliation></author><author><name sortKey="Lim, Wei Shen" sort="Lim, Wei Shen" uniqKey="Lim W" first="Wei Shen" last="Lim">Wei Shen Lim</name><affiliation><nlm:affiliation>Respiratory Medicine, Nottingham University Hospitals NHS Trust.</nlm:affiliation><wicri:noCountry code="subField">Nottingham University Hospitals NHS Trust</wicri:noCountry></affiliation></author><author><name sortKey="Makki, Sophia" sort="Makki, Sophia" uniqKey="Makki S" first="Sophia" last="Makki">Sophia Makki</name><affiliation><nlm:affiliation>East Midlands Centre, Public Health England.</nlm:affiliation><wicri:noCountry code="subField">Public Health England</wicri:noCountry></affiliation></author><author><name sortKey="Rooney, Kevin D" sort="Rooney, Kevin D" uniqKey="Rooney K" first="Kevin D" last="Rooney">Kevin D. Rooney</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Care and Practice Improvement, University of the West of Scotland, Hamilton, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Care and Practice Improvement, University of the West of Scotland, Hamilton</wicri:regionArea><wicri:noRegion>Hamilton</wicri:noRegion></affiliation></author><author><name sortKey="Nguyen Van Tam, Jonathan S" sort="Nguyen Van Tam, Jonathan S" uniqKey="Nguyen Van Tam J" first="Jonathan S" last="Nguyen-Van-Tam">Jonathan S. Nguyen-Van-Tam</name></author><author><name sortKey="Beck, Charles R" sort="Beck, Charles R" uniqKey="Beck C" first="Charles R" last="Beck">Charles R. Beck</name><affiliation wicri:level="4"><nlm:affiliation>Division of Epidemiology and Public Health, University of Nottingham, Nottingham.</nlm:affiliation><orgName type="university">Université de Nottingham</orgName><country>Royaume-Uni</country><placeName><settlement type="city">Nottingham</settlement><region type="nation">Angleterre</region><region type="région" nuts="1">Nottinghamshire</region></placeName></affiliation></author></analytic><series><title level="j">The Journal of infectious diseases</title><idno type="eISSN">1537-6613</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans</term><term>Immunoglobulins (administration & dosage)</term><term>Immunoglobulins (immunology)</term><term>Influenza, Human (drug therapy)</term><term>Influenza, Human (immunology)</term><term>Plasma (immunology)</term><term>Prospective Studies</term><term>Respiratory Tract Infections (immunology)</term><term>Risk</term><term>SARS Virus (immunology)</term><term>Severe Acute Respiratory Syndrome (drug therapy)</term><term>Severe Acute Respiratory Syndrome (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Grippe humaine (immunologie)</term><term>Grippe humaine (traitement médicamenteux)</term><term>Humains</term><term>Immunoglobulines (administration et posologie)</term><term>Immunoglobulines (immunologie)</term><term>Infections de l'appareil respiratoire (immunologie)</term><term>Plasma sanguin (immunologie)</term><term>Risque</term><term>Syndrome respiratoire aigu sévère (immunologie)</term><term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term><term>Virus du SRAS (immunologie)</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Immunoglobulins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Immunoglobulins</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Immunoglobulines</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term><term>Immunoglobulines</term><term>Infections de l'appareil respiratoire</term><term>Plasma sanguin</term><term>Syndrome respiratoire aigu sévère</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term><term>Plasma</term><term>Respiratory Tract Infections</term><term>SARS Virus</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Prospective Studies</term><term>Risk</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Risque</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Administration of convalescent plasma, serum, or hyperimmune immunoglobulin may be of clinical benefit for treatment of severe acute respiratory infections (SARIs) of viral etiology. We conducted a systematic review and exploratory meta-analysis to assess the overall evidence.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25030060</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>12</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN><JournalIssue CitedMedium="Internet"><Volume>211</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of infectious diseases</Title><ISOAbbreviation>J. Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.</ArticleTitle><Pagination><MedlinePgn>80-90</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiu396</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Administration of convalescent plasma, serum, or hyperimmune immunoglobulin may be of clinical benefit for treatment of severe acute respiratory infections (SARIs) of viral etiology. We conducted a systematic review and exploratory meta-analysis to assess the overall evidence.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Healthcare databases and sources of grey literature were searched in July 2013. All records were screened against the protocol eligibility criteria, using a 3-stage process. Data extraction and risk of bias assessments were undertaken.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 32 studies of SARS coronavirus infection and severe influenza. Narrative analyses revealed consistent evidence for a reduction in mortality, especially when convalescent plasma is administered early after symptom onset. Exploratory post hoc meta-analysis showed a statistically significant reduction in the pooled odds of mortality following treatment, compared with placebo or no therapy (odds ratio, 0.25; 95% confidence interval, .14-.45; I(2) = 0%). Studies were commonly of low or very low quality, lacked control groups, and at moderate or high risk of bias. Sources of clinical and methodological heterogeneity were identified.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Convalescent plasma may reduce mortality and appears safe. This therapy should be studied within the context of a well-designed clinical trial or other formal evaluation, including for treatment of Middle East respiratory syndrome coronavirus CoV infection.</AbstractText><CopyrightInformation>© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mair-Jenkins</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>East Midlands Centre, Public Health England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saavedra-Campos</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Field Epidemiology Training Programme, Public Health England, London Field Epidemiology Service, Public Health England, Liverpool.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baillie</LastName><ForeName>J Kenneth</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Roslin Institute, University of Edinburgh, Midlothian.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cleary</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Field Epidemiology Service, Public Health England, Liverpool.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khaw</LastName><ForeName>Fu-Meng</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>East Midlands Centre, Public Health England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Wei Shen</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Nottingham University Hospitals NHS Trust.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makki</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>East Midlands Centre, Public Health England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rooney</LastName><ForeName>Kevin D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Institute of Care and Practice Improvement, University of the West of Scotland, Hamilton, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Van-Tam</LastName><ForeName>Jonathan S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Beck</LastName><ForeName>Charles R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Division of Epidemiology and Public Health, University of Nottingham, Nottingham.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Convalescent Plasma Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Infect Dis</MedlineTA><NlmUniqueID>0413675</NlmUniqueID><ISSNLinking>0022-1899</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007136">Immunoglobulins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Infect Dis. 2020 Apr;20(4):398-400</RefSource><PMID Version="1">32113510</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007136" MajorTopicYN="N">Immunoglobulins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MERS coronavirus</Keyword><Keyword MajorTopicYN="N">convalescent plasma</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">severe acute respiratory infection</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25030060</ArticleId><ArticleId IdType="pii">jiu396</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiu396</ArticleId><ArticleId IdType="pmc">PMC4264590</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin Infect Dis. 2011 Feb 15;52(4):447-56</Citation><ArticleIdList><ArticleId IdType="pubmed">21248066</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15616839</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Antimicrob Chemother. 2005 Nov;56(5):919-22</Citation><ArticleIdList><ArticleId IdType="pubmed">16183666</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Transfus Apher Sci. 2003 Aug;29(1):101</Citation><ArticleIdList><ArticleId IdType="pubmed">12952008</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Ann Intern Med. 2006 Oct 17;145(8):599-609</Citation><ArticleIdList><ArticleId IdType="pubmed">16940336</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Chest. 2013 Aug;144(2):464-473</Citation><ArticleIdList><ArticleId IdType="pubmed">23450336</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Zhonghua Yi Xue Za Zhi. 2003 Jun 25;83(12):1018-22</Citation><ArticleIdList><ArticleId IdType="pubmed">12899773</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Hong Kong Med J. 2003 Jun;9(3):199-201</Citation><ArticleIdList><ArticleId IdType="pubmed">12777656</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2007 Oct 4;357(14):1450-1</Citation><ArticleIdList><ArticleId IdType="pubmed">17914053</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS One. 2008 Aug 21;3(8):e2985</Citation><ArticleIdList><ArticleId IdType="pubmed">18716658</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS Med. 2009 Jul 21;6(7):e1000097</Citation><ArticleIdList><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>World J Gastroenterol. 2003 Jun;9(6):1139-43</Citation><ArticleIdList><ArticleId IdType="pubmed">12800213</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2009 May;32(5):356-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19799070</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS Med. 2006 Sep;3(9):e343</Citation><ArticleIdList><ArticleId IdType="pubmed">16968120</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Hong Kong Med J. 2006 Dec;12(6):489</Citation><ArticleIdList><ArticleId IdType="pubmed">17148811</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2005 Sep;24(9):583-91</Citation><ArticleIdList><ArticleId IdType="pubmed">16172857</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Crit Care Med. 2013 May;41(5):1345-52</Citation><ArticleIdList><ArticleId IdType="pubmed">23399939</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Transfusion. 2010 Jun;50(6):1384-98</Citation><ArticleIdList><ArticleId IdType="pubmed">20158681</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Hong Kong Med J. 2010 Dec;16(6):447-54</Citation><ArticleIdList><ArticleId IdType="pubmed">21135421</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Antimicrob Chemother. 2008 Sep;62(3):437-41</Citation><ArticleIdList><ArticleId IdType="pubmed">18565970</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Microbiol Infect. 2004 Jul;10(7):676-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15214887</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS One. 2011;6(12):e29249</Citation><ArticleIdList><ArticleId IdType="pubmed">22216224</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS Curr. 2013 Nov 12;5:</Citation><ArticleIdList><ArticleId IdType="pubmed">24270606</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Hong Kong Med J. 2003 Aug;9(4):309; author reply 310</Citation><ArticleIdList><ArticleId IdType="pubmed">12904626</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Nottinghamshire</li><li>Écosse</li></region><settlement><li>Nottingham</li><li>Édimbourg</li></settlement><orgName><li>Université d'Édimbourg</li><li>Université de Nottingham</li></orgName></list><tree><noCountry><name sortKey="Cleary, Paul" sort="Cleary, Paul" uniqKey="Cleary P" first="Paul" last="Cleary">Paul Cleary</name><name sortKey="Khaw, Fu Meng" sort="Khaw, Fu Meng" uniqKey="Khaw F" first="Fu-Meng" last="Khaw">Fu-Meng Khaw</name><name sortKey="Lim, Wei Shen" sort="Lim, Wei Shen" uniqKey="Lim W" first="Wei Shen" last="Lim">Wei Shen Lim</name><name sortKey="Mair Jenkins, John" sort="Mair Jenkins, John" uniqKey="Mair Jenkins J" first="John" last="Mair-Jenkins">John Mair-Jenkins</name><name sortKey="Makki, Sophia" sort="Makki, Sophia" uniqKey="Makki S" first="Sophia" last="Makki">Sophia Makki</name><name sortKey="Nguyen Van Tam, Jonathan S" sort="Nguyen Van Tam, Jonathan S" uniqKey="Nguyen Van Tam J" first="Jonathan S" last="Nguyen-Van-Tam">Jonathan S. Nguyen-Van-Tam</name><name sortKey="Saavedra Campos, Maria" sort="Saavedra Campos, Maria" uniqKey="Saavedra Campos M" first="Maria" last="Saavedra-Campos">Maria Saavedra-Campos</name></noCountry><country name="Royaume-Uni"><region name="Écosse"><name sortKey="Baillie, J Kenneth" sort="Baillie, J Kenneth" uniqKey="Baillie J" first="J Kenneth" last="Baillie">J Kenneth Baillie</name></region><name sortKey="Beck, Charles R" sort="Beck, Charles R" uniqKey="Beck C" first="Charles R" last="Beck">Charles R. Beck</name><name sortKey="Rooney, Kevin D" sort="Rooney, Kevin D" uniqKey="Rooney K" first="Kevin D" last="Rooney">Kevin D. Rooney</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E35 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000E35 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:25030060
|texte= The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:25030060" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |